非酒精性脂肪性肝病：内脏脂肪组织的作用
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue.
作者信息
Hanlon Courtney L, Yuan Liyun
机构信息
Department of Medicine University of Southern California Keck School of Medicine of USC Los Angeles CA.
Division of Gastrointestinal and Liver Diseases University of Southern California Keck Hospital of USC Los Angeles CA.
出版信息
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):106-110. doi: 10.1002/cld.1183. eCollection 2022 Mar.
Abstract
Content available: Author Audio Recording.
摘要
内容提供
作者音频记录。
相似文献
1
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue.
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):106-110. doi: 10.1002/cld.1183. eCollection 2022 Mar.
2
Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21. doi: 10.1111/j.1530-0277.2006.00281.x.
3
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
Liver Int. 2019 Feb;39(2):332-341. doi: 10.1111/liv.13983. Epub 2018 Oct 27.
4
Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.
Ann Hepatol. 2010 Jul-Sep;9(3):266-70.
5
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):157-161. doi: 10.1002/cld.1250. eCollection 2022 Nov.
6
Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease.
Medicine (Baltimore). 2015 Mar;94(9):e573. doi: 10.1097/MD.0000000000000573.
7
Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
Dig Liver Dis. 2008 Feb;40(2):132-9. doi: 10.1016/j.dld.2007.09.009. Epub 2007 Dec 21.
8
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
J Gastroenterol. 2006 May;41(5):462-9. doi: 10.1007/s00535-006-1790-5.
9
Improvement in nonalcoholic fatty liver disease through bariatric surgery.
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
10
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease.
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):166-169. doi: 10.1002/cld.1255. eCollection 2022 Nov.
引用本文的文献
1
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia.
J Diabetes Res. 2025 Aug 23;2025:5555842. doi: 10.1155/jdr/5555842. eCollection 2025.
2
Prolonged Water-Only Fasting Followed by a Whole-Plant-Food Diet Promotes Fat-Free Mass Recovery and Continued Fat Mass Loss in Adults With Overweight or Obesity.
Obes Sci Pract. 2025 Aug 5;11(4):e70086. doi: 10.1002/osp4.70086. eCollection 2025 Aug.
3
In-vivo liver proton density fat fraction quantification at 0.55 T: a pilot study with comparison against 3 T MRI.
MAGMA. 2025 Jul 15. doi: 10.1007/s10334-025-01277-9.
4
Effect of lean status on the mortality of patients with non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
Pak J Med Sci. 2025 Jun;41(6):1845-1853. doi: 10.12669/pjms.41.6.12044.
5
The interplay between white adipose tissue, adipokines, and structural gray matter changes.
Hum Brain Mapp. 2024 Jun 15;45(9):e26752. doi: 10.1002/hbm.26752.
6
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial.
BMC Med. 2025 May 7;23(1):266. doi: 10.1186/s12916-025-04017-x.
7
The effect of aldafermin expressing-Escherichia coli Nissle 1917 along with dietary change on visceral adipose tissue in MASLD mouse model.
Int J Obes (Lond). 2025 Apr 10. doi: 10.1038/s41366-025-01774-w.
8
Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome.
Eur Cardiol. 2024 May 9;19:e03. doi: 10.15420/ecr.2023.26. eCollection 2024.
9
Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet.
Front Nutr. 2024 Mar 20;11:1366883. doi: 10.3389/fnut.2024.1366883. eCollection 2024.
10
White adipose tissue distribution and amount are associated with increased white matter connectivity.
Hum Brain Mapp. 2024 Apr;45(5):e26654. doi: 10.1002/hbm.26654.
本文引用的文献
1
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.
Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4.
2
Adiponectin and leptin in the diagnosis and therapy of NAFLD.
Metabolism. 2020 Feb;103:154028. doi: 10.1016/j.metabol.2019.154028. Epub 2019 Nov 27.
3
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10.
4
Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.
Sci Rep. 2019 Jul 4;9(1):9693. doi: 10.1038/s41598-019-46187-8.
5
Body Composition Profiling in the UK Biobank Imaging Study.
Obesity (Silver Spring). 2018 Nov;26(11):1785-1795. doi: 10.1002/oby.22210. Epub 2018 May 22.
6
Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
Circulation. 2018 Mar 27;137(13):1391-1406. doi: 10.1161/CIRCULATIONAHA.117.029617.
7
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study.
Diabetes Ther. 2017 Aug;8(4):851-861. doi: 10.1007/s13300-017-0279-y. Epub 2017 Jun 14.
8
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis.
JAMA Intern Med. 2017 May 1;177(5):633-640. doi: 10.1001/jamainternmed.2016.9607.
9
Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.
Metabolism. 2016 Sep;65(9):1297-306. doi: 10.1016/j.metabol.2016.05.013. Epub 2016 May 27.
10
Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).
Am J Cardiol. 2015 Feb 1;115(3):307-15. doi: 10.1016/j.amjcard.2014.10.039. Epub 2014 Nov 13.
Zotero 插件